{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T04:54:55Z","timestamp":1781585695268,"version":"3.54.5"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2021,5,22]],"date-time":"2021-05-22T00:00:00Z","timestamp":1621641600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,5,22]],"date-time":"2021-05-22T00:00:00Z","timestamp":1621641600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1007\/s00467-021-05111-x","type":"journal-article","created":{"date-parts":[[2021,5,22]],"date-time":"2021-05-22T09:03:02Z","timestamp":1621674182000},"page":"3771-3776","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Favipiravir use in children with COVID-19 and acute kidney injury: is it safe?"],"prefix":"10.1007","volume":"36","author":[{"given":"Yasemin","family":"Ozsurekci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pembe Derin","family":"Oygar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sibel La\u00e7inel","family":"G\u00fcrlevik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selman","family":"Kesici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seza","family":"Ozen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eda Didem","family":"Kurt Sukur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bora","family":"G\u00fclhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rezan","family":"Topaloglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benan","family":"Bayrakci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali B\u00fclent","family":"Cengiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,22]]},"reference":[{"key":"5111_CR1","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1001\/jamapediatrics.2020.1467","volume":"174","author":"R Castagnoli","year":"2020","unstructured":"Castagnoli R, Votto M, Licari A, Brambilla I, Bruno R, Perlini S, Rovida F, Baldanti F, Marseglia GL (2020) Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in children and adolescents: a systematic review. JAMA Pediatr 174:882\u2013889","journal-title":"JAMA Pediatr"},{"key":"5111_CR2","doi-asserted-by":"publisher","first-page":"101623","DOI":"10.1016\/j.tmaid.2020.101623","volume":"34","author":"AJ Rodriguez-Morales","year":"2020","unstructured":"Rodriguez-Morales AJ, Cardona-Ospina JA, Gutierrez-Ocampo E, Villamizar-Pena R, Holguin-Rivera Y, Escalera-Antezana JP, Alvarado-Arnez LE, Bonilla-Aldana DK, Franco-Paredes C, Henao-Martinez AF, Paniz-Mondolfi A, Lagos-Grisales GJ, Ramirez-Vallejo E, Suarez JA, Zambrano LI, Villamil-Gomez WE, Balbin-Ramon GJ, Rabaan AA, Harapan H, Dhama K, Nishiura H, Kataoka H, Ahmad T, Sah R, Latin American Network of Coronavirus Disease 2019-COVID-19 Research (LANCOVID-19) (2020) Clinical, laboratory and imaging features of COVID-19: a systematic review and meta-analysis. Travel Med Infect Dis 34:101623","journal-title":"Travel Med Infect Dis"},{"key":"5111_CR3","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1111\/apa.15270","volume":"109","author":"JF Ludvigsson","year":"2020","unstructured":"Ludvigsson JF (2020) Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults. Acta Paediatr 109:1088\u20131095","journal-title":"Acta Paediatr"},{"key":"5111_CR4","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1056\/NEJMc2005073","volume":"382","author":"X Lu","year":"2020","unstructured":"Lu X, Zhang L, Du H, Zhang J, Li YY, Qu J, Zhang W, Wang Y, Bao S, Li Y, Wu C, Liu H, Liu D, Shao J, Peng X, Yang Y, Liu Z, Xiang Y, Zhang F, Silva RM, Pinkerton KE, Shen K, Xiao H, Xu S, Wong GWK (2020) SARS-CoV-2 infection in children. N Engl J Med 382:1663\u20131665","journal-title":"N Engl J Med"},{"key":"5111_CR5","first-page":"341","volume":"37","author":"BC Cura Yayla","year":"2020","unstructured":"Cura Yayla BC, Ozsurekci Y, Aykac K, Derin Oygar P, Lacinel Gurlevik S, \u0130lbay S, Kukul MG, Karahan S, Cengiz AB, Ceyhan M (2020) Characteristics and management of children with COVID-19 in Turkey. Balkan Med J 37:341\u2013347","journal-title":"Balkan Med J"},{"key":"5111_CR6","doi-asserted-by":"publisher","first-page":"e0005389","DOI":"10.1371\/journal.pntd.0005389","volume":"11","author":"THT Nguyen","year":"2017","unstructured":"Nguyen THT, Guedj J, Anglaret X, Laouenan C, Madelain V, Taburet AM, Baize S, Sissoko D, Pastorino B, Rodallec A, Piorkowski G, Carazo S, Conde MN, Gala JL, Bore JA, Carbonnelle C, Jacquot F, Raoul H, Malvy D, Lamballerie X, Mentre F, JIKI study group (2017) Favipiravir pharmacokinetics in Ebola-infected patients of the JIKI trial reveals concentrations lower than targeted. PLoS Negl Trop Dis 11:e0005389","journal-title":"PLoS Negl Trop Dis"},{"key":"5111_CR7","unstructured":"Japanese Pharmaceuticals and Medical Devices Agency (PMDA) (2014) Report on the deliberation results. https:\/\/www.pmda.go.jp\/files\/000210319.pdf. Accessed 26 March 2021"},{"key":"5111_CR8","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S2055-6640(20)30016-9","volume":"6","author":"V Pilkington","year":"2020","unstructured":"Pilkington V, Repperel T, Hill A (2020) A review of the safety of favipiravir - a potential treatment in the COVID-19 pandemic? J Virus Erad 6:45\u201351","journal-title":"J Virus Erad"},{"key":"5111_CR9","doi-asserted-by":"publisher","first-page":"866","DOI":"10.5414\/CP202388","volume":"53","author":"Y Kumagai","year":"2015","unstructured":"Kumagai Y, Murakawa Y, Hasunama T, Aso M, Yuji W, Sakurai T, Noto M, Oe T, Kaneko A (2015) Lack of effect of favipiravir, a novel antiviral agent, on the QT interval in healthy Japanese adults. Int J Clin Pharm Ther 53:866\u2013874","journal-title":"Int J Clin Pharm Ther"},{"key":"5111_CR10","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s40268-020-00333-0","volume":"21","author":"F Marra","year":"2021","unstructured":"Marra F, Smolders EJ, El-Sherif O, Boyle A, Davidson K, Sommerville AJ, Marzolini C, Siccardi M, Burger D, Gibbons S, Khoo S, Back D (2021) Recommendations for dosing of repurposed COVID-19 medications in patients with renal and hepatic impairment. Drugs R&D 21:9\u201327","journal-title":"Drugs R&D"},{"key":"5111_CR11","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1007\/s12519-020-00362-4","volume":"16","author":"KL Shen","year":"2020","unstructured":"Shen KL, Yang YH, Jiang RM, Wang TY, Zhao DC, Jiang Y, Lu XX, Jin RM, Zheng YJ, Xu BP, Xie ZD, Liu ZS, Li XW, Lin LK, Shang YX, Shu SN, Bai Y, Lu M, Lu G, Deng JK, Luo WJ, Xiong LJ, Liu M, Cui YX, Ye LP, Li JF, Shao JB, Gao LW, Wang YY, Wang XF (2020) Updated diagnosis, treatment and prevention of COVID-19 in children: experts\u2019 consensus statement (condensed version of the second edition). World J Pediatr 16:232\u2013239","journal-title":"World J Pediatr"},{"key":"5111_CR12","first-page":"712","volume":"58","author":"Y Dong","year":"2020","unstructured":"Dong Y, Mo X, Hu Y, Qi X, Jaing F, Jiang Z, Tong S (2020) Epidemiological characteristics of 2143 pediatric patients with 2019 coronavirus disease in China. Pediatrics 58:712\u2013713","journal-title":"Pediatrics"},{"key":"5111_CR13","unstructured":"Centers for Disease Control and Prevention (2020) Multisystem inflammatory syndrome in children (MIS-C) associated with coronavirus disease 2019 (COVID-19). https:\/\/emergency.cdc.gov\/han\/2020\/han00432.asp. Accessed 10 November 2020"},{"key":"5111_CR14","unstructured":"World Health Organization (2020) Multisystem inflammatory syndrome in children and adolescents with COVID-19. www.who.int\/publications-detail\/multisystem-inflammatory-syndrome-in-children-and-adolescents-with-covid-19. Accessed 10 November 2020"},{"key":"5111_CR15","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1007\/s00467-020-04633-0","volume":"35","author":"J Laycock","year":"2020","unstructured":"Laycock J, Baum M, Rees L (2020) KDIGO nomenclature glossary for pediatric nephrology. Pediatr Nephrol 35:2201\u20132203","journal-title":"Pediatr Nephrol"},{"key":"5111_CR16","first-page":"424","volume":"23","author":"E Muhari-Stark","year":"2018","unstructured":"Muhari-Stark E, Burckart GJ (2018) Glomerular filtration rate estimation formulas for pediatric and neonatal use. J Pediatr Pharmacol Ther 23:424\u2013431","journal-title":"J Pediatr Pharmacol Ther"},{"key":"5111_CR17","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/S0140-6736(15)60232-X","volume":"385","author":"N Bouazza","year":"2015","unstructured":"Bouazza N, Treluyer JM, Foissac F, Mentre F, Taburet AM, Guedj J, Anglaret X, Lamballerie X, Keita S, Malvy D, Frange P (2015) Favipiravir for children with Ebola. Lancet 385:603\u2013604","journal-title":"Lancet"},{"key":"5111_CR18","unstructured":"Toyama Chemical Company (2017) Favipiravir (Avigan). Drug insert. https:\/\/www.cdc.gov.tw\/File\/Get\/ht8jUiB_MI-aKnlwstwzvw. Accessed 28 January 2020"},{"key":"5111_CR19","unstructured":"United States Food and Drug Administration (FDA) (2020) Emergency use authorization (EUA). Fact sheet for healthcare providers emergency use authorization (EUA) of Veklury\u00ae (remdesivir) for hospitalized pediatric patients weighing 3.5 kg to less than 40 kg or hospitalized pediatric patients less than 12 years of age weighing at least 3.5 kg. https:\/\/www.fda.gov\/media\/137566\/download. Accessed 27 March 2021"},{"key":"5111_CR20","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1056\/NEJMoa2001282","volume":"382","author":"B Cao","year":"2020","unstructured":"Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G, Ruan L, Song B, Cai Y, Wei M, Li X, Xia J, Chen N, Xiang J, Yu T, Bai T, Xie X, Zhang L, Li C, Yuan Y, Chen H, Li H, Huang H, Tu S, Gong F, Liu Y, Wei Y, Dong C, Zhou F, Gu X, Xu J, Liu Z, Zhang Y, Li H, Shang L, Wang K, Li K, Zhou X, Dong X, Qu Z, Lu S, Hu X, Ruan S, Luo S, Wu J, Peng L, Cheng F, Pan L, Zou J, Jia C, Wang J, Liu X, Wang S, Wu X, Ge Q, He J, Zhan H, Qiu F, Guo L, Huang C, Jaki T, Hayden FG, Horby PW, Zhang D, Wang C (2020) A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19. N Engl J Med 382:1787\u20131799","journal-title":"N Engl J Med"},{"key":"5111_CR21","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1056\/NEJMoa2012410","volume":"382","author":"J Geleris","year":"2020","unstructured":"Geleris J, Sun Y, Platt J, Zucker J, Baldwin M, Hripcsak G, Labella A, Manson DK, Kubin C, Barr RG, Sobieszcyk ME, Schluger NW (2020) Observational study of hydroxychloroquine in hospitalized patients with Covid-19. N Engl J Med 382:2411\u20132418","journal-title":"N Engl J Med"},{"key":"5111_CR22","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1001\/jama.2020.8630","volume":"323","author":"ES Rosenberg","year":"2020","unstructured":"Rosenberg ES, Dufort EM, Udo T, Wilberschied LA, Kumar J, Tesoriero J, Weinberg P, Kirkwood J, Muse A, DeHovitz J, Blog DS, Hutton B, Holtgrave DR, Zucker HA (2020) Association of treatment with hydroxychloroquine or azithromycin with in-hospital mortality in patients with COVID-19 in New York State. JAMA 323:2493\u20132502","journal-title":"JAMA"},{"key":"5111_CR23","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1002\/cpt.1844","volume":"108","author":"YX Du","year":"2020","unstructured":"Du YX, Chen XP (2020) Favipiravir: pharmacokinetics and concerns about clinical trials for 2019-nCoV Infection. Clin Pharmacol Ther 108:242\u2013247","journal-title":"Clin Pharmacol Ther"},{"key":"5111_CR24","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.kint.2020.05.006","volume":"98","author":"JS Hirsch","year":"2020","unstructured":"Hirsch JS, Ng JH, Ross DW, Sharma P, Shah HH, Barnett RL, Hazzan AD, Fishbane S, Jhaveri KD (2020) Acute kidney injury in patients hospitalized with COVID-19. Kidney Int 98:209\u2013218","journal-title":"Kidney Int"},{"key":"5111_CR25","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1007\/s00134-020-06153-9","volume":"46","author":"P Gabarre","year":"2020","unstructured":"Gabarre P, Dumas G, Dupont T, Darmon M, Azoulay E, Zafrani L (2020) Acute kidney injury in critically ill patients with COVID-19. Intensive Care Med 46:1339\u20131348","journal-title":"Intensive Care Med"},{"key":"5111_CR26","unstructured":"Medical Dialogues Bureau (2021) Favipiravir use in COVID-19 patients may lead to nephrotoxicity: case study. https:\/\/medicaldialogues.in\/medicine\/news\/favipiravir-use-in-covid-19-patients-may-lead-to-nephrotoxicity-case-study-73398. Accessed 28 January 2021"},{"key":"5111_CR27","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1016\/j.kint.2020.03.015","volume":"7","author":"H Izzedine","year":"2020","unstructured":"Izzedine H, Jhaveri KD, Perazelli MA (2020) COVID-19 therapeutic options for patients with kidney disease. Kidney Int 7:1297\u20131298","journal-title":"Kidney Int"},{"key":"5111_CR28","unstructured":"Sise ME (2020) Pharmacologic treatment of COVID-19: what nephrologists need to know. https:\/\/advances.massgeneral.org\/research-and-innovation\/article.aspx?id=1224. Accessed 28 January 2021"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-021-05111-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-021-05111-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-021-05111-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T17:10:06Z","timestamp":1637255406000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-021-05111-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,22]]},"references-count":28,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["5111"],"URL":"https:\/\/doi.org\/10.1007\/s00467-021-05111-x","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,22]]},"assertion":[{"value":"4 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2021","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The author's name Eda Didem Kurt Sukur was tagged incorrectly. The first name is \"Eda Didem\" and the last name is \"Kurt Sukur\".","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}